Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more
May 9, 2017
7:44
Episode Description
May 09, 2017 edition of the weekly JAMA Editors' Summary
Proudly Supported by
May 09, 2017 edition of the weekly JAMA Editors' Summary
